← Open Payments lookup

MEI TSAN LI: Open Payments

NPI 1043880685 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$574 in 20 payments from 10 companies in 2025. Trend: 2023 $392 · 2024 $370 · 2025 $574

Food & beverage: $574
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$134
GlaxoSmithKline, LLC.4$103
Astellas Pharma US Inc3$95
SOBI, INC2$61
Incyte Corporation2$50
ABBVIE INC.1$33
Takeda Pharmaceuticals U.S.A., Inc.1$30
Rigel Pharmaceuticals, Inc.1$27
Syndax Pharmaceuticals, Inc.1$27
Azurity Pharmaceuticals, Inc.1$15

Products named: CALQUENCE, OJJAARA, Cresemba, Vonjo, JAKAFI, EPKINLY, Xospata, ICLUSIG.

Industry payments across TX — which companies pay providers there.